Citadel Advisors’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-52,300
Closed -$1.21M 15330
2021
Q3
$1.21M Buy
52,300
+18,700
+56% +$444K ﹤0.01% 7666
2021
Q2
$884K Sell
33,600
-4,900
-13% -$123K ﹤0.01% 8675
2021
Q1
$859K Buy
38,500
+11,394
+42% +$261K ﹤0.01% 8483
2020
Q4
$531K Buy
27,106
+10,306
+61% +$171K ﹤0.01% 8039
2020
Q3
$236K Sell
16,800
-64,200
-79% -$927K ﹤0.01% 8557
2020
Q2
$918K Buy
81,000
+43,800
+118% +$400K ﹤0.01% 5992
2020
Q1
$234K Buy
37,200
+23,800
+178% +$384K ﹤0.01% 7744
2019
Q4
$273K Sell
13,400
-12,100
-47% -$226K ﹤0.01% 7742
2019
Q3
$424K Buy
25,500
+7,600
+42% +$131K ﹤0.01% 7029
2019
Q2
$294K Sell
17,900
-3,900
-18% -$75.3K ﹤0.01% 7616
2019
Q1
$383K Sell
21,800
-9,600
-31% -$204K ﹤0.01% 7240
2018
Q4
$779K Buy
31,400
+4,000
+15% +$133K ﹤0.01% 5703
2018
Q3
$881K Buy
+27,400
New +$935K ﹤0.01% 5774
2015
Q4
Sell
-6,400
Closed -$71K 9382
2015
Q3
$71K Sell
6,400
-2,200
-26% -$26.9K ﹤0.01% 7290
2015
Q2
$103K Buy
8,600
+1,100
+15% +$18.3K ﹤0.01% 7046
2015
Q1
$148K Buy
7,500
+200
+3% +$4.18K ﹤0.01% 6502
2014
Q4
$145K Buy
7,300
+3,200
+78% +$52.3K ﹤0.01% 6314
2014
Q3
$66K Sell
4,100
-6,600
-62% -$112K ﹤0.01% 6715
2014
Q2
$188K Buy
10,700
+5,600
+110% +$96.2K ﹤0.01% 5636
2014
Q1
$87K Sell
5,100
-41,700
-89% -$642K ﹤0.01% 6331
2013
Q4
$718K Buy
46,800
+40,500
+643% +$575K ﹤0.01% 3578
2013
Q3
$117K Buy
+6,300
New +$114K ﹤0.01% 5231

Other funds holding TVTY

Citadel Advisors's TVTY Position: Q2 2022 in Review

Citadel Advisors sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 163,892 shares — an estimated $5.27M sold.

Citadel Advisors first reported a position in TVTY in Q3 2013 and held it in 30 quarters. The position peaked at $14.6M in Q4 2018. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • Citadel Advisors reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 163,892 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $5.27M.
  • Citadel Advisors first reported a position in Tivity Health, Inc. Common Stock in Q3 2013 and held it in 30 quarters.
  • Citadel Advisors's Tivity Health, Inc. Common Stock position peaked at $14.6M in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.